More generally, the study presented here demonstrates a novel research pipeline for the evaluation of NHE6 variants found in CS patients, including the evaluation of the functional effects of variants in vivo when expressed under the endogenous promoter. This evidence concerns the gene SLC9A6 and Cowden syndrome 1.